Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Y2K compliance

This article was originally published in The Tan Sheet

Executive Summary

The vast majority of pharmaceutical manufacturers are prepared for the Y2K computer glitch, an FDA survey and audit program shows. The survey was sent to 4,228 firms; of the 474 recipients classified as OTC drug manufacturers, 73.4% responded. Overall, the survey elicited a 74.5% response rate, with 94.4% saying they would be ready for Y2K by Oct. 30. The audit program was 88% complete as of October, with 183 companies expected to be visited. So far, 92% of the companies FDA has audited have been classified as prepared for Y2K

Topics

UsernamePublicRestriction

Register

PS090631

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel